Dr Reddy's Laboratories reply to clarification sought by exchange

05 Apr 2022 Evaluate

Dr Reddy's Laboratories has informed that the Exchange had sought clarification with respect to news article appearing on https://economictimes.indiatimes.com dated March 31, 2022 titled ‘Himachal Pradesh high court restrains DRL from selling BI’s diabetic drug Jardiance’. Dr Reddys Laboratory’s response is enclosed.

The above information is a part of company’s filings submitted to BSE.

Dr. Reddys Lab Share Price

1274.25 24.05 (1.92%)
31-Oct-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1849.05
Dr. Reddys Lab 1274.25
Cipla 1553.20
Lupin 2184.00
Zydus Lifesciences 1001.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.